The Importance of Preclinical Pharmacodynamic Evaluation in New Drug Development: A Case Study of Antidepressants

被引:0
|
作者
Li, Deshang [1 ]
机构
[1] Shandong Univ, Weihai Marine Coll, Weihai 264209, Shandong, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
32
引用
收藏
页码:25 / 26
页数:2
相关论文
共 50 条
  • [1] Preclinical pharmacodynamic evaluation of antibiotic nitroxoline for anticancer drug repurposing
    Zhang, Qi
    Wang, Shanshan
    Yang, Dexuan
    Pan, Kevin
    Li, Linna
    Yuan, Shoujun
    ONCOLOGY LETTERS, 2016, 11 (05) : 3265 - 3272
  • [2] PHARMACODYNAMIC MODELING - APPLICATION TO NEW DRUG DEVELOPMENT
    KROBOTH, PD
    SCHMITH, VD
    SMITH, RB
    CLINICAL PHARMACOKINETICS, 1991, 20 (02) : 91 - 98
  • [3] Drug surveillance of new antidepressants: Evaluation of neurobehavioral impact
    Blayac, JP
    HillaireBuys, D
    Peyriere, H
    THERAPIE, 1997, 52 (02): : 117 - 122
  • [4] New generation drug development from in-silico identification to preclinical evaluation in glioblastoma
    Arunachalam, Mahesh
    Gaikwad, Shreyas
    Ramachandran, Sharavan
    Srivastava, Sanjay K.
    CANCER RESEARCH, 2024, 84 (06)
  • [5] Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance
    Eva Germovsek
    Charlotte I. S. Barker
    Mike Sharland
    Joseph F. Standing
    Clinical Pharmacokinetics, 2019, 58 : 39 - 52
  • [6] Effective incorporation of preclinical information in the decision-making process for new drug development: An anonymous case study.
    Bies, R
    Ko, H
    Desjardins, R
    Gobburu, J
    Peck, C
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 107 - 107
  • [7] Pharmaco-electroencephalography and pharmacokinetic-pharmacodynamic modeling in drug development: Focus on preclinical steps
    Danhof, M
    Visser, SAG
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2002, 24 : 127 - 128
  • [8] PHARMACODYNAMIC STUDY UPON A NEW ANTIASTHMATIC DRUG - SALBUTAMOL
    FOUSSARDBLANPIN, O
    NARCISSE, G
    THERAPIE, 1971, 26 (06): : 1081 - +
  • [10] Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance
    Germovsek, Eva
    Barker, Charlotte I. S.
    Sharland, Mike
    Standing, Joseph F.
    CLINICAL PHARMACOKINETICS, 2019, 58 (01) : 39 - 52